Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

0 Hinnangud
0
Osa
51 of 144
Kestus
33 min
Keel
inglise
Vorming
Kategooria
Majandus ja ettevõtlus

Private-debt firms are set to consolidate as larger companies dominate deal flow, according to Marc Chowrimootoo, portfolio manager at Hayfin Capital Management. “We’re seeing a concentration within fewer hands,” Chowrimootoo tells Bloomberg News’ Lisa Lee and James Crombie and Bloomberg Intelligence’s Julie Hung in the latest Credit Edge podcast. “That trend is going to continue.” He identifies debt refinancing as the big opportunity for private lenders in 2024. Hayfin likes the health-care and software sectors, while avoiding smaller borrowers that are struggling with higher rates. In addition, BI’s Hung weighs the impact on food and drink companies of weight-loss drugs like Ozempic.

See omnystudio.com/listener for privacy information.


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Proovi tasuta
Device Banner Block-copy 894x1036
Cover for Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Muud podcastid, mis võivad sulle meeldida ...